Stockreport

Biotech Sinks As Debate Weighs On Cancer Treatment Rivalry [Investor's Business Daily]

Blueprint Medicines Corporation  (BPMC) 
Last blueprint medicines corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: blueprintmedicines.com
PDF Related news Blueprint Medicines ( BPMC ) sank to a two-month low Monday as investors compared its thyroid cancer treatment to a rival therapy from Loxo Oncology ( LOXO [Read more]